Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126991541 | 12699154 | 1 | I | 20160524 | 20160817 | 20160830 | 20160830 | PER | US-PFIZER INC-2016392977 | PFIZER | 38.00 | YR | M | Y | 95.25000 | KG | 20160830 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126991541 | 12699154 | 1 | PS | GENOTROPIN | SOMATROPIN | 1 | Subcutaneous | 0.2 ML, DAILY | M83322 | 20280 | .2 | ML | POWDER FOR SOLUTION FOR INJECTION | ||||||
| 126991541 | 12699154 | 2 | SS | GENOTROPIN | SOMATROPIN | 1 | Subcutaneous | 0.4 ML, DAILY | M83322 | 20280 | .4 | ML | POWDER FOR SOLUTION FOR INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126991541 | 12699154 | 1 | Hormone replacement therapy |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126991541 | 12699154 | Dizziness | |
| 126991541 | 12699154 | Incorrect dose administered | |
| 126991541 | 12699154 | Wrong technique in product usage process |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126991541 | 12699154 | 2 | 2016 | 0 |